235 related articles for article (PubMed ID: 19307987)
1. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment.
Pappadopulos E; Jensen PS; Chait AR; Arnold LE; Swanson JM; Greenhill LL; Hechtman L; Chuang S; Wells KC; Pelham W; Cooper T; Elliott G; Newcorn JH
J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):501-510. PubMed ID: 19307987
[TBL] [Abstract][Full Text] [Related]
2. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder.
Arch Gen Psychiatry; 1999 Dec; 56(12):1088-96. PubMed ID: 10591284
[TBL] [Abstract][Full Text] [Related]
3. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.
Pelham WE; Gnagy EM; Burrows-Maclean L; Williams A; Fabiano GA; Morrisey SM; Chronis AM; Forehand GL; Nguyen CA; Hoffman MT; Lock TM; Fielbelkorn K; Coles EK; Panahon CJ; Steiner RL; Meichenbaum DL; Onyango AN; Morse GD
Pediatrics; 2001 Jun; 107(6):E105. PubMed ID: 11389303
[TBL] [Abstract][Full Text] [Related]
4. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.
Arch Gen Psychiatry; 1999 Dec; 56(12):1073-86. PubMed ID: 10591283
[TBL] [Abstract][Full Text] [Related]
5. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
[TBL] [Abstract][Full Text] [Related]
6. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
7. National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.
Gau SS; Chen SJ; Chou WJ; Cheng H; Tang CS; Chang HL; Tzang RF; Wu YY; Huang YF; Chou MC; Liang HY; Hsu YC; Lu HH; Huang YS
J Clin Psychiatry; 2008 Jan; 69(1):131-40. PubMed ID: 18312048
[TBL] [Abstract][Full Text] [Related]
8. Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: a 6-month follow-up.
Duric NS; Assmus J; Gundersen D; Duric Golos A; Elgen IB
Nord J Psychiatry; 2017 Jul; 71(5):386-394. PubMed ID: 28345387
[TBL] [Abstract][Full Text] [Related]
9. Parental knowledge of attention-deficit hyperactivity disorder and opinions of treatment options: impact on enrollment and adherence to a 12-month treatment trial.
Corkum P; Rimer P; Schachar R
Can J Psychiatry; 1999 Dec; 44(10):1043-8. PubMed ID: 10637684
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of Effectiveness of Parent Behavioral Management Training and Methylphenidate on Reduction of Symptomsof Attention Deficit Hyperactivity Disorder.
Mohammadi MR; Soleimani AA; Ahmadi N; Davoodi E
Acta Med Iran; 2016 Aug; 54(8):503-509. PubMed ID: 27701720
[TBL] [Abstract][Full Text] [Related]
11. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers.
Jensen PS; Hinshaw SP; Swanson JM; Greenhill LL; Conners CK; Arnold LE; Abikoff HB; Elliott G; Hechtman L; Hoza B; March JS; Newcorn JH; Severe JB; Vitiello B; Wells K; Wigal T
J Dev Behav Pediatr; 2001 Feb; 22(1):60-73. PubMed ID: 11265923
[TBL] [Abstract][Full Text] [Related]
12. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
[TBL] [Abstract][Full Text] [Related]
13. Review of medication adherence in children and adults with ADHD.
Adler LD; Nierenberg AA
Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302
[TBL] [Abstract][Full Text] [Related]
14. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
Wang LJ; Chen CK; Huang YS
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
[TBL] [Abstract][Full Text] [Related]
16. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
[TBL] [Abstract][Full Text] [Related]
17. Medication treatment strategies in the MTA Study: relevance to clinicians and researchers.
Greenhill LL; Abikoff HB; Arnold LE; Cantwell DP; Conners CK; Elliott G; Hechtman L; Hinshaw SP; Hoza B; Jensen PS; March JS; Newcorn J; Pelham WE; Severe JB; Swanson JM; Vitiello B; Wells K
J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1304-13. PubMed ID: 8885584
[TBL] [Abstract][Full Text] [Related]
18. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
Barner JC; Khoza S; Oladapo A
Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
[TBL] [Abstract][Full Text] [Related]
19. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
[TBL] [Abstract][Full Text] [Related]
20. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
Stein MA; Sarampote CS; Waldman ID; Robb AS; Conlon C; Pearl PL; Black DO; Seymour KE; Newcorn JH
Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
